NCT00791063View on ClinicalTrials.gov

18F ML-10 for Early Detection of Response of Brain Metastases to WBRT

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Solid TumorsBrain Metastases
Interventions
OTHER

18F ML-10

Patients will undergo 2-3 brain PET/CT sessions; A pre-treatment session and 1-2 sessions post WBRT treatment. Each PET/CT session will be done following intravenous administration of 18F-ML-10, to assess tracer uptake by the tumor.

Sponsors

Lead Sponsor

Aposense Ltd.
All Listed Sponsors
lead

Aposense Ltd.

INDUSTRY